|
|
||||||||
REPORTS
Department of Physiology, Queen's University, and Gastrointestinal Disease Research Unit, Department of Medicine, Kingston General Hospital, Kingston, Ontario, Canada
Submitted 8 March 2007 ; accepted in final form 23 April 2007
ABSTRACT
To understand the role of the colonic extracellular calcium-sensing receptor (CaSR) in calcium chemoprotection against colon cancer, we activated the CaSR with 5 mM Ca2+ on HT-29 cells, an adenocarcinoma cell line. High Ca2+ stimulated the upregulation (as assessed by RT-PCR) and the secretion of Wnt5a (assessed by Western blot), a noncanonical Wnt family member. Inhibiting CaSR activity with a short interfering RNA (siRNA) duplex against the CaSR reduced CaSR protein and prevented the secretion of Wnt5a. Dominant negative CaSR (R185Q) or siRNA blocked the high Ca2+-mediated inhibition of the
-catenin reporter TOPflash. The CaSR/Wnt5a inhibition of
-catenin reporter was prevented by dominant negative ubiquitin ligase seven in absentia homolog 2 (Siah2). In low-calcium medium, overexpressing Wnt5a increased Siah2 amplicons and protein. Inducing the expression of full-length adenomatous polyposis coli (APC) prevented CaSRmediated increases of Siah2 and Wnt5a. Overexpressing the receptor tyrosine kinase-like orphan receptor 2 (Ror2) increased Wnt5a and CaSR-mediated inhibition of TOPflash. Conditioned medium from Wnt5a-transfected cells added to HT-29 cells in low-Ca2+ medium inhibited the
-catenin reporter. This inhibition was blocked dose responsively by Frizzled-8/Fc chimeric antibody. Overexpression of Ror2 in HT-29 cells in low-Ca2+ medium increased the inhibition of
-catenin reporter caused by recombinant Wnt5a protein compared with addition of Wnt5a protein alone. Our findings demonstrate that APC status plays a key role as a determinant of Wnt5a secretion and suggest that CaSR-mediated secretion of Wnt5a will inhibit defective Wnt signaling in APC-truncated cells in an autocrine manner.
chemoprevention
This article has been cited by other articles:
![]() |
D J Mulder, I Pacheco, D J Hurlbut, N Mak, G T Furuta, R J MacLeod, and C J Justinich FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis Gut, February 1, 2009; 58(2): 166 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. DeMorrow, H. Francis, E. Gaudio, J. Venter, A. Franchitto, S. Kopriva, P. Onori, R. Mancinelli, G. Frampton, M. Coufal, et al. The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway Am J Physiol Gastrointest Liver Physiol, December 1, 2008; 295(6): G1150 - G1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Justinich, N. Mak, I. Pacheco, D. Mulder, R. W. Wells, M. G. Blennerhassett, and R. J. MacLeod The extracellular calcium-sensing receptor (CaSR) on human esophagus and evidence of expression of the CaSR on the esophageal epithelial cell line (HET-1A) Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G120 - G129. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |